Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFMO Chemoprevention in Familial Prostate Cancer
NCT00006101Phase 2Completed
- Start
- Oct 1998
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eflornithine in prostate cancer (PCa). Started Oct 1998; status: completed.
02
Drugs
eflornithine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00006101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006101.